Page last updated: 2024-08-21

ethyl pyruvate and Carcinoma, Hepatocellular

ethyl pyruvate has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, K; Cheng, P; Dai, W; Guo, CY; Li, J; Lu, J; Shen, M; Wang, C; Wang, F; Xu, L; Yang, J; Zhang, H; Zhang, Y; Zheng, Y; Zhu, R1

Other Studies

1 other study(ies) available for ethyl pyruvate and Carcinoma, Hepatocellular

ArticleYear
Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
    Biochemical and biophysical research communications, 2014, Jan-24, Volume: 443, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Glycation End Products, Advanced; Hep G2 Cells; HMGB1 Protein; Humans; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; Oncogene Protein v-akt; Proto-Oncogene Proteins c-bcl-2; Pyruvates; Signal Transduction; Xenograft Model Antitumor Assays

2014